Previous Close | 86.66 |
Open | 86.51 |
Bid | 87.36 x 0 |
Ask | 87.37 x 0 |
Day's Range | 86.51 - 87.37 |
52 Week Range | 79.06 - 94.52 |
Volume | |
Avg. Volume | 3,220,997 |
Market Cap | 178.587B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | 23.61 |
EPS (TTM) | 3.70 |
Earnings Date | Apr 23, 2024 |
Forward Dividend & Yield | 3.30 (3.78%) |
Ex-Dividend Date | Mar 07, 2024 |
1y Target Est | 86.92 |
Subscribe to Yahoo Finance Plus to view Fair Value for NOVN.SW
Zacks.com users have recently been watching Novartis (NVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novartis (NVS) closed at $95.88 in the latest trading session, marking a +0.64% move from the prior day.
Mesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate, remestemcel-L, is sufficient to support a regulatory filing for pediatric SR-aGVHD indication.